» Articles » PMID: 2051750

Neurotoxic Esterase (NTE) Assay: Optimized Conditions Based on Detergent-induced Shifts in the Phenol/4-aminoantipyrine Chromophore Spectrum

Overview
Journal J Anal Toxicol
Specialty Toxicology
Date 1991 Mar 1
PMID 2051750
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

An assay for neurotoxic esterase (neuropathy target esterase, NTE) was developed by Johnson (1,2) to assess the delayed neurotoxic potential of organophosphorus compounds. NTE activity is calculated from the rate of phenyl valerate hydrolysis resistant to paraoxon and sensitive to mipafox inhibition under specified conditions of inhibitor concentrations, pH, temperature, and incubation times with inhibitors and substrate. The amount of phenol produced is measured colorimetrically after its oxidative coupling with 4-aminoantipyrine to yield 4-N-(1,4-benzoquinoneimine)-antipyrine, a chromophore with a wavelength of maximum absorbance (lambda m) 510 nm and corresponding molar absorptivity (molar extinction coefficient, epsilon) equal to 13,900 M-1cm-1. The assay was improved and simplified later by Johnson (3) without any change in the lambda m or epsilon, even though the chromophore solvent was altered by adding the detergent, sodium dodecyl sulfate (SDS). The present work demonstrates that when the NTE assay is performed according to the improved procedure, with a final [SDS] of 3.0 mg/mL, the lambda m of the chromophore in the assay mixture is shifted from 510 to 490 nm. The same shift in the chromophore lambda m is observed when phenol standards are coupled with 4-aminoantipyrine in solutions containing 3.0 mg/mL SDS. A systematic investigation of the dependence of the lambda m of the chromophore on [SDS] in the assay mixture revealed that the spectral shift increases rapidly at an [SDS] greater than the apparent critical micelle concentration (CMC; estimated to be 0.53 mg/mL under these conditions) and begins to plateau at [SDS] greater than 10 mg/mL.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders.

Liu J, He Y, Lwin C, Han M, Guan B, Naik A Brain. 2024; 147(6):2085-2097.

PMID: 38735647 PMC: 11146429. DOI: 10.1093/brain/awae055.


Loss of in Neurons Contributes to Neurodegeneration with Mitochondria Abnormalities, Reactive Oxygen Species Acceleration and Accumulation of Lipid Droplets in Brain.

Melentev P, Ryabova E, Surina N, Zhmujdina D, Komissarov A, Ivanova E Int J Mol Sci. 2021; 22(15).

PMID: 34361042 PMC: 8347196. DOI: 10.3390/ijms22158275.


Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Richardson R, Fink J, Glynn P, Hufnagel R, Makhaeva G, Wijeyesakere S Adv Neurotoxicol. 2020; 4:1-78.

PMID: 32518884 PMC: 7271139. DOI: 10.1016/bs.ant.2020.01.001.


Activation of Neuregulin 1/ErbB Signaling Is Involved in the Development of TOCP-Induced Delayed Neuropathy.

Xu H, Wang P, Sun Y, Xu M, Zhu L, Wu Y Front Mol Neurosci. 2018; 11:129.

PMID: 29740279 PMC: 5925568. DOI: 10.3389/fnmol.2018.00129.


Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.

Castilhos L, de Oliveira J, Adefegha S, Magni L, Doleski P, Abdalla F Redox Rep. 2017; 22(6):451-459.

PMID: 28209096 PMC: 6837566. DOI: 10.1080/13510002.2017.1288973.